Saudi Arabia Anti Aging Therapeutics Market Report 2022 to 2030

Saudi Arabia Anti Aging Therapeutics Market Analysis

$ 3999

Saudi Arabia's anti-aging therapeutics market is projected to grow from $10 Mn in 2022 to $39 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The rising awareness in the Saudi Arabian population about anti-aging treatments and therapies is the major growth driver in the market. The Saudi Arabian anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and distribution channel. Voirx, Wayakit, and IRIDEX Corporation are some of the key companies in the market.

ID: IN10SAPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: Saudi Arabia AUTHOR: Parul Choudhary

Buy Now

Saudi Arabia Anti-Aging Therapeutics Market Executive Summary

Saudi Arabia's anti-aging therapeutics market is projected to grow from $10 Mn in 2022 to $39 Mn in 2030 with a CAGR of 18.03% for the year 2022-30. A $296 Bn budget for 2023 has been revealed by Saudi Arabia, with projections for $301 Bn in revenue and a $4.26 Bn surplus. $50.4 Bn has been set aside for social and health growth. The Saudi royal family has established the Revolution Foundation, a non-profit group with spending caps of up to $1 Bn annually supporting fundamental studies on the biology of aging and looking for ways to increase the number of years people can live in good health, a notion known as health span, with its oil riches.

Like in other parts of the globe, Saudi Arabia has witnessed a rise in the field of anti-aging therapeutics. These treatments are particularly appealing to those who want to keep a youthful appearance, lower their risk of developing age-related illnesses, and enhance their general quality of life because they work to slow down or reverse the effects of aging on the human body. Stem cell treatment, skin creams, hormone replacement therapy, and dietary supplements are some of the most widely used anti-aging therapeutics in Saudi Arabia. These treatments are usually provided by licensed healthcare professionals and are governed by Saudi Food and Drug Authority regulations.

In Saudi Arabia, dietary supplements are a prevalent anti-aging treatment method and can contain vitamins, minerals, antioxidants, and other nutrients thought to have anti-aging qualities. Retinol, hyaluronic acid, and peptides are examples of ingredients that may be found in skin creams and other topical treatments and are believed to help reduce the appearance of wrinkles and other aging signs. Another well-liked anti-aging treatment in Saudi Arabia is hormone replacement therapy (HRT), which is used to replace hormones like estrogen and testosterone that decrease with aging. HRT can increase energy levels, enhance sexual function, and lower the chance of osteoporosis. A more recent type of anti-aging treatment that is gaining popularity in Saudi Arabia is stem cell therapy. This treatment uses stem cells to repair damaged tissue and bring back the functionality of ill or aging systems.

Saudi Arabia Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

In Saudi Arabia, there is a rising awareness of the advantages of anti-aging treatments, and many people are looking for methods to look younger and improve their general health and well-being. Anti-aging therapeutics have benefited from significant technological advancements, making treatments more efficient and available to a broader range of patients in Saudi Arabia. Saudi Arabia is investing more money in research and development related to anti-aging medicines, which has resulted in the development of fresh and cutting-edge therapies.

Market Restraints

A cultural mindset exists in Saudi Arabia that values aging and the knowledge and experience that come with it. This mindset might make some people less interested in anti-aging therapies, which might reduce the market desire for these medications. Although many anti-aging therapeutics are usually safe and well-tolerated, some treatments raise safety questions. For instance, some patients may be reluctant to use treatments like hormone replacement therapy because it is known to increase the risk of certain cancers and other illnesses.

Competitive Landscape

Key Players

Tawasef Biotech (SAU)
Rose Aljazera (SAU)
Alawi Tunsi Hospital (SAU)
Voirx (SAU)
Wayakit (SAU)
IRIDEX Corporation
DEKA Medical
ENDYMED
Fotona
LUTRONIC
Quanta System
SharpLight Technologies

Healthcare Policies and Regulatory Landscape

The Saudi Food and Drug Authority (SFDA) is the authority in charge of regulating and monitoring the licensing of anti-aging medications in Saudi Arabia. All facets of the Saudi Arabian pharmaceutical business, such as the registration, licensing, and monitoring of medications, are subject to regulation by the SFDA. A manufacturer must send a thorough application to the SFDA detailing the anti-aging drug's safety, effectiveness, and manufacturing procedures in order to get approval for it in Saudi Arabia. The SFDA will then examine the application and assess the medication to see if it complies with the required safety and efficacy requirements. The drug will be given marketing authorization, enabling it to be sold and distributed in Saudi Arabia, if the SFDA authorizes it. After a drug has been authorized, the SFDA monitors it and has the authority to act if there are any safety issues or if the drug turns out to be ineffective.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.